	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	243	300	297	392	363	366	546	702	689	911	1,267	1,650	866	638	667	698
Cost of Operating Revenue	136	167	171	239	201	242	412	507	487	683	946	1,264	576	364	340	365
Gross Profit	108	132	126	154	163	124	135	195	202	228	321	386	290	274	327	333
Gross Margin	44.2	44.1	42.5	39.2	44.7	33.9	24.6	27.8	29.3	25.1	25.4	23.4	33.5	42.9	49.0	47.7
Total Operating Expenses	206	279	283	364	331	341	517	646	637	831	1,136	1,489	766	551	584	614
Operating Profit	38	21	14	29	33	25	29	56	52	80	131	161	100	86	83	83
Operating Margin	15.5	7.0	4.7	7.3	9.0	6.9	5.4	7.9	7.5	8.8	10.4	9.8	11.6	13.6	12.5	11.9
Financing Income/(Expense) - Net	-7	-8	-9	-12	-9	-6	-9	-15	-7	0	2	21	11	26	42	-2
Profit before Taxes	28	13	12	26	25	15	37	42	45	81	137	190	107	119	121	123
Income Taxes	9	4	4	6	7	-4	0	22	8	20	34	36	28	32	31	32
Profit after Tax	18	9	7	19	25	18	37	20	38	61	103	154	79	90	91	93
PAT Margin	7.5	3.1	2.5	4.9	6.9	5.0	6.7	2.9	5.5	6.7	8.1	9.3	9.1	14.1	13.7	13.3
EPS - Basic - ex Extraordinary Items	13.02	6.53	5.05	13.16	17.02	11.86	22.45	11.90	22.08	35.29	59.88	89.87	46.06	52.47	53.27	54.05
EPS - Diluted - ex Extraordinary Items	13.02	6.53	5.05	13.16	17.02	10.71	21.33	11.90	22.08	35.29	59.88	89.87	46.06	52.47	53.27	54.05
EBIT	38	21	14	29	33	25	29	56	52	80	131	161	100	86	83	83
EBITDA	50	34	29	39	42	50	48	101	102	131	151	181	111	93	90	90
EBITDA Margin	20.5	11.4	9.7	9.8	11.6	13.6	8.8	14.3	14.8	14.4	11.9	11.0	12.8	14.7	13.5	13.0

Balance Sheet

Abridged

Understanding Balance Sheet

Sree Rayalaseema Hi-Strength Hypo Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	AR
Total Current Assets	100	94	118	114	106	104	147	195	248	314	482	554	529	581	658
Long-Term Investments	22	27	31	23	41	49	105	65	42	74	35	55	76	119	140
Property Plant & Equipment - Net	161	207	200	199	191	185	194	194	141	111	130	116	120	127	87
Total Non-Current Assets	211	264	250	245	247	248	314	275	197	205	306	391	385	488	457
Total Assets	311	358	367	358	353	352	460	470	445	519	788	945	914	1,070	1,115
Total Current Liabilities	99	110	128	124	103	77	113	118	115	118	205	133	54	65	63
Long Term Debt	60	72	56	39	25	20	22	6	10	9	8	9	12	11	9
Total Non-Current Liabilities	83	108	90	63	47	38	28	25	17	12	12	60	58	72	68
Total Liabilities	182	218	218	187	150	114	141	143	132	130	217	193	113	136	130
Total Shareholders' Equity	128	140	149	172	203	237	319	326	313	389	571	752	801	919	972
Minority Interest	-	-	-	-	-	-	-	-	-	-	0	0	0	14	13
Total Equity	128	140	149	172	203	237	319	326	313	389	571	752	801	933	985
Total Liabilities & Equity	311	358	367	358	353	352	460	470	445	519	788	945	914	1,070	1,115

Cash Flow

Abridged

Understanding Cash Flow Statement

Sree Rayalaseema Hi-Strength Hypo Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	29.27	22.49	22.35	39.13	34.78	33.68	43.97	73.31	85.56	95.28	120.95	159.08	86.77	93.65	97.04
Working Capital - Increase/(Decrease)	-14.28	24.20	-2.41	-3.13	-13.65	7.28	-45.53	-28.79	6.45	-25.35	-59.19	-10.35	63.54	-1.63	-21.27
Net CF from Operating Activities	14.98	46.69	19.94	36.00	21.13	40.96	-1.56	44.51	92.00	69.94	61.76	148.73	150.31	92.02	75.77
Capital Expenditures - Net	66.25	59.74	7.80	22.08	6.81	18.70	27.98	44.94	8.06	20.44	14.41	8.32	19.77	2.41	1.27
Net CF from Investing Activities	-84.19	-68.00	-9.12	-4.78	-9.46	-19.50	-27.69	-24.07	-39.42	-119.35	-5.58	-121.33	-34.60	-35.52	-0.32
Dividends Paid - Cash - Total	-	-	-	2.65	2.66	2.66	2.80	3.93	4.14	4.29	5.15	6.01	6.87	5.15	5.15
Stock - Issuance/(Retirement) - Net	48.94	1.23	2.20	-	-	11.71	6.00	6.32	-	-	-	0.10	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	17.61	19.02	-10.61	-22.45	-10.59	-22.11	19.94	-24.04	-8.57	19.04	-43.77	-8.99	-5.97	-11.68	-5.11
Net Cash Flow from Financing Activities	69.59	21.16	-8.59	-32.43	-11.99	-13.06	23.15	-21.64	-12.71	14.75	-48.92	-14.89	-12.84	-16.83	-10.26
Free Cash Flow to Equity	-33.66	5.97	1.53	-8.53	3.73	0.14	-9.59	-24.47	75.38	68.54	3.58	131.43	124.56	77.92	69.39
Free Operating CF net dividend	-51.27	-13.05	12.14	11.27	11.66	19.60	-32.33	-4.36	79.81	45.20	42.20	134.41	123.42	84.43	64.28
Free Operating CF	-51.27	-13.05	12.14	13.92	14.32	22.26	-29.54	-0.43	83.95	49.50	47.35	140.41	130.28	89.58	69.43

Business Segment Analysis

FY End:

Mar 26

Sree Rayalaseema Hi-Strength Hypo Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Chemicals (100.0%)₹ 6.34 Cr

Revenue / Sales

Chemicals (100.0%)₹ 666.96 Cr

Assets

Chemicals (100.0%)₹ 1,115.37 Cr

Operating Income

Chemicals (100.0%)₹ 83.09 Cr

Regional Segment Analysis

FY End:

Mar 26

Sree Rayalaseema Hi-Strength Hypo Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (61.7%)₹ 411.53 CrRest of the world (38.3%)₹ 255.43 Cr

Historical Segment Analysis

Track how Sree Rayalaseema Hi-Strength Hypo Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2026 Mar 31
	2026 Mar 31
Chemicals	6

Frequently Asked Questions

What is the revenue of Sree Rayalaseema Hi-Strength Hypo Ltd.?

The latest trailing twelve month revenue of Sree Rayalaseema Hi-Strength Hypo Ltd. is ₹ 697.65 Cr, reflecting a 1-year growth of 7.42% and a 3-year CAGR of -19.58%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Sree Rayalaseema Hi-Strength Hypo Ltd.?

The latest trailing twelve month net profit (PAT) of Sree Rayalaseema Hi-Strength Hypo Ltd. is ₹ 91.84 Cr, with a 3-year earnings CAGR of -13.40%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Sree Rayalaseema Hi-Strength Hypo Ltd.?

The trailing twelve month EBITDA of Sree Rayalaseema Hi-Strength Hypo Ltd. is approximately ₹ 84.97 Cr (based on an operating margin of 12.18%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Sree Rayalaseema Hi-Strength Hypo Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Sree Rayalaseema Hi-Strength Hypo Ltd. is 53.97. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Sree Rayalaseema Hi-Strength Hypo Ltd.?

The debt-to-equity ratio of Sree Rayalaseema Hi-Strength Hypo Ltd. stands at 0.01. The interest coverage ratio is 47.24x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Sree Rayalaseema Hi-Strength Hypo Ltd.?

The estimated book value per share of Sree Rayalaseema Hi-Strength Hypo Ltd. is 566.13 (derived from a P/B ratio of 0.84 and market price of ₹ 473.25), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Sree Rayalaseema Hi-Strength Hypo Ltd.?

The trailing twelve month operating cash flow of Sree Rayalaseema Hi-Strength Hypo Ltd. is ₹ 75.77 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Sree Rayalaseema Hi-Strength Hypo Ltd. report consolidated or standalone financials?

Sree Rayalaseema Hi-Strength Hypo Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.